Neuronetics, Inc. (STIM): R&D Expense
$6.58M
Year ended 2025-12-31
$5.87M
Trailing 12 months to 2026-06-30
-11.0%
3-year compound annual growth
-6.5%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.58M | -48.4% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $12.77M | +34.2% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $9.52M | +1.9% | 2026-03-17, From 2023-01-01 |
| 2022-12-31 | $9.34M | +17.8% | 2025-03-27, From 2022-01-01 |
| 2021-12-31 | $7.92M | -13.9% | 2024-03-08, From 2021-01-01 |
| 2020-12-31 | $9.20M | -33.1% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | $13.75M | +67.0% | 2022-03-08, From 2019-01-01 |
| 2018-12-31 | $8.23M | +3.7% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $7.94M | -3.5% | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | $8.22M | n/a | 2019-03-05, From 2016-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | 2025-12-31 | $6.58M | -48.4% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $2.10M | -11.9% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $64.92M | +49.2% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $42.53M | +63.3% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $25.77M | +0.9% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $17.45M | +5.4% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $20.28M | -1.5% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $34.79M | +32.9% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $27.89M | +17.9% |
Compare STIM, XTNT, HTFL, OSUR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗